Carlo Lanza, MD, PhD
Executive Medical Officer

Carlo Lanza, MD, PhD, is executive medical officer for Labcorp Clinical Development Services, based in Lugano, Switzerland. Dr. Lanza performs medical monitoring and safety assessments on Phase I-IV clinical trials for Labcorp clients. He leads early phase and translational research early development programs with targeted therapies, small molecules, biologics and gene therapy. Dr. Lanza also oversees development of late-stage development strategies and delivery and approval of registrational programs. He brings more than 20 years of experience in clinical research and development as a physician and medical director, specializing in pediatrics and oncology. Before joining Labcorp, he served as medical director for medicines at Malaria Venture in Geneva, Switzerland. Dr. Lanza also has held leadership positions with Novartis Oncology, Pfizer Global Research and Development, and AstraZeneca U.K. He joined Labcorp in 2012.